Salim Dhanji

Vermögen: 21 Mio $ am 31.05.2024

44 Jahre

Health Technology

Consumer Services

Aktive Positionen von Salim Dhanji

Unternehmen	Position	Beginn	Ende
ME THERAPEUTICS HOLDINGS INC.	Direktor/Vorstandsmitglied	09.03.2023	-
ME THERAPEUTICS HOLDINGS INC.	Vorstandsvorsitzender	09.03.2023	-

Unternehmen	Position	Beginn	Ende
Qu Biologics, Inc. Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.	Corporate Officer/Principal	01.01.2009	01.01.2014

University of British Columbia

Doctorate Degree

International

Kanada

Operativ

Sektoral

Health Technology	3
Consumer Services	2

Besetzte Positionen

Aktive

Inaktive

Börsennotierte Unternehmen

Private Unternehmen

Börsennotierte Unternehmen	1
ME THERAPEUTICS HOLDINGS INC.	Health Technology

Private Unternehmen	1
Qu Biologics, Inc. Qu Biologics, Inc. BiotechnologyHealth Technology Qu Biologics, Inc. develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer. The firm specializes in ulcerative colitis, Crohn's disease, arthritis, cancer, autoimmune diseases, autoimmune disorders, inflammatory bowel disease, IBD, Site Specific Immunomodulators, immunotherapies, investigational drug, auto-immune, pharmaceuticals, research, inflammation, biotech and clinical trials. The company was founded by Harold David Gunn and Rob Freeman in 2007 and is headquartered in Burnaby, Canada.	Health Technology

Private Unternehmen

Health Technology